Stockscreener 앱 받기
15.37
0.13%
0.02
Aardvark Therapeutics Inc 주식(AARD)의 최신 뉴스
Aardvark Therapeutics, Inc. (NASDAQ:AARD) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Aardvark Therapeutics (NASDAQ:AARD) Trading 2.5% Higher – Time to Buy? - Defense World
Aardvark Therapeutics (NASDAQ:AARD) Trading 2.5% HigherTime to Buy? - MarketBeat
Treasury Yields: How Aardvark Therapeutics Inc stock compares to growth peersJuly 2025 Summary & Long-Term Capital Growth Ideas - Bộ Nội Vụ
RSI Check: Can Aardvark Therapeutics Inc stock rebound after recent weaknessMarket Activity Summary & High Conviction Buy Zone Alerts - Bộ Nội Vụ
Aardvark Therapeutics updates investor presentation on hunger therapies - TipRanks
Aardvark Therapeutics, Inc Updates Corporate Presentation - TradingView — Track All Markets
Raymond James reiterates Strong Buy on Aardvark Therapeutics stock with $47 target - Investing.com Australia
What risks investors should watch in Aardvark Therapeutics Inc. stockBull Run & Safe Capital Growth Tips - Улправда
Can Aardvark Therapeutics Inc. stock attract ESG capital inflowsJuly 2025 Spike Watch & Comprehensive Market Scan Insights - Улправда
Will Aardvark Therapeutics Inc. stock deliver consistent dividendsPortfolio Return Report & AI Powered Buy/Sell Recommendations - Улправда
Fed Watch: How Aardvark Therapeutics Inc. stock trades during market volatility2025 Trade Ideas & Free Fast Gain Swing Trade Alerts - Улправда
Nasdaq Moves: How Aardvark Therapeutics Inc. stock trades during market volatilityQuarterly Portfolio Summary & Technical Buy Zone Confirmation - Улправда
What AI ML Trends Might Elevate Advance Metering Technology Limiteds Stock ProspectsLong-Term Growth Stocks & Free Unstoppable Trading Performance - earlytimes.in
Aug Gainers: Will Aardvark Therapeutics Inc stock deliver consistent dividends2025 Momentum Check & Community Trade Idea Sharing Platform - moha.gov.vn
Aardvark Therapeutics up 9% at $10.10 after Raymond James Strong Buy initiation - MSN
Aardvark Therapeutics prices $94M IPO at $16 per share - MSN
Critical Contrast: Aardvark Therapeutics (AARD) and The Competition - Defense World
Aardvark Therapeutics (AARD) – Investment Analysts’ Recent Ratings Updates - Defense World
Aardvark Therapeutics initiated with an outperform at Oppenheimer - MSN
Oppenheimer initiates Aardvark Therapeutics stock with Outperform rating By Investing.com - Investing.com South Africa
Oppenheimer initiates Aardvark Therapeutics stock with Outperform rating - Investing.com India
Oppenheimer Initiates Coverage of Aardvark Therapeutics (AARD) with Outperform Recommendation - Nasdaq
Aardvark Therapeutics, Inc.(NasdaqGS: AARD) added to NASDAQ Biotechnology Index - marketscreener.com
Aardvark Therapeutics, Inc. (NASDAQ:AARD) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Aardvark Therapeutics, Inc. (NASDAQ:AARD) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Is Aardvark Therapeutics Inc. stock attractive for hedge fundsTrade Analysis Summary & Risk Adjusted Buy/Sell Alerts - bolumsonucanavari.com
Will Aardvark Therapeutics Inc. stock maintain dividend yieldJuly 2025 Sector Moves & Smart Money Movement Tracker - DonanımHaber
How resilient is Aardvark Therapeutics Inc. stock in market downturns2025 Market Sentiment & Technical Pattern Based Signals - Улправда
Insider Buying: Aardvark Therapeutics CEO, Secretary & Director Bought US$101k Of Shares - simplywall.st
HC Wainwright Has Negative Outlook for AARD FY2025 Earnings - MarketBeat
Aardvark Therapeutics (NASDAQ:AARD) CEO Tien-Li Lee Purchases 7,000 Shares - MarketBeat
Aardvark Therapeutics (NASDAQ:AARD) CFO Purchases $43,200.00 in Stock - MarketBeat
Insider Stock Purchases: December 13, 2025 - Quiver Quantitative
Analysts’ Top Healthcare Picks: Aardvark Therapeutics, Inc. (AARD), Eli Lilly & Co (LLY) - The Globe and Mail
William Blair initiates coverage on Aardvark Therapeutics stock with Outperform rating - Investing.com Canada
Sun Nelson, CFO, buys Aardvark Therapeutics shares worth $43,200 By Investing.com - Investing.com Nigeria
Insider Buying: Nelson Sun Acquires Additional Shares of Aardvar - GuruFocus
Lee Tien-Li, CEO of Aardvark, buys $101k in AARD stock - Investing.com Australia
Sun Nelson, CFO, buys Aardvark Therapeutics shares worth $43,200 - Investing.com
Aardvark Therapeutics Executives Increase Their Holdings - TradingView — Track All Markets
CFO Sun Buys 3,000 ($43.2K) Of Aardvark Therapeutics Inc [AARD] - TradingView — Track All Markets
William Blair Initiates Coverage of Aardvark Therapeutics (AARD) with Outperform Recommendation - Nasdaq
Aardvark's Hunger Suppressing Drug Candidate Could Potentially Address Massive $10 Billion Market: Analyst - Sahm
William Blair Initiates Aardvark Therapeutics With Outperform Rating - marketscreener.com
4.73%
0.92%
자본화:
|
볼륨(24시간):